• Home
  • AASLD Year in Review

The Engine of Hepatology: AASLD Year in Review

The AASLD is pleased to announce the completion of our annually highly anticipated 2023 Year in Review:  

Below is an inclusive reflection of achievements and endeavors for both the AASLD and AASLD Foundation over the past year. From leading the field in MASLD resources to funding over $2 million to the next generation of hepatology leaders, this review encapsulates the dynamic journey of how AASLD is shaping the future of liver disease and improving liver care worldwide. The engine of hepatology begins and continues with AASLD as we keep the momentum to achieve our 2024 strategic goals.

AASLD: The Engine of Hepatology  

  • AASLD redesigned the 2023 Distinguished Awards process by enhancing the overall recognition of the award and increasing the number of nominations, especially from underrepresented groups.
  • The 2022 Transplant Hepatology Board Review Course moved to a new platform on LiverLearning which is accessible to AASLD Members.  
  • AASLD’s annual Liver Meeting (TLM) received 2,465 total abstract submissions with 2,225 Poster Presentations, 224 Parallel Sessions, and 16 Plenary Presentations held over 4 plenary sessions.  
  • AASLD’s Publications received over 4,500 submissions.  

Leading the Specialty: A Finely Tuned Machine

  • To support the announcement of the new MASLD/MASH nomenclature, AASLD created a robust online Resource Center (translated into multiple languages) that houses a decision tree tool and infographic, PowerPoint presentations, videos, and webinar that discuss the implementation.  
  • AASLD participated in the submission of a proposal to modify ICD-10-CM coding to include the new nomenclature and meetings with key stakeholders remain ongoing through 2024.
  • AASLD built a hepatitis C advocacy coalition of providers and patients and gathered over 70 signatures for a hepatitis C rural health letter to Congress.
  • AASLD is advocating for a National Liver Disease Strategy and continues its Congressional Briefing Series to educate Capitol Hill staff on liver health with webinars on hepatitis C and liver cancer.
  • AASLD along with other multinational liver societies called for action to support the transgender community.
  • At DDW 2023, over 100 abstract presentations and 87 invited session presentations were programmed by AASLD.  
  • AASLD completed the transition to a new publishing partner and spent 2023 working strategically to maximize the author, reviewer, and reader experience to maintain and elevate AASLD's journal position as a leading resource.  

Professional Development: Propelled Forward  

  • AASLD selected their inaugural recipient of AASLD Harold Amos Award, Dr. Ashley Spann.  
  • In 2023, AASLD issued over 9,500 CE credits.
  • AASLD published five Practice Guidances:  
    • Acute on Chronic Liver Failure & ICU Care    
    • Hepatocellular Carcinoma    
    • Non-alcoholic Fatty Liver Disease, now known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)    
    • Portal Hypertension in Cirrhosis  
    • TIPS, Variceal Embolization, and Retrograde Transvenous Obliteration in the Management of Variceal Hemorrhage    
  • The Practice Metrics Committee finalized two Quality Measures Papers on the management of coagulopathy and pre-liver transplant care—now published in AASLD publication’s Hepatology.
  • In 2023, 760 attendees claimed over 2,700 CEM credits for AASLD programming at DDW.  
  • 1,572 participants requested CME credits for AASLD’s annual flagship event, The Liver Meeting.
  • AASLD partnered with Target RWE to relaunch the Cirrhosis Quality Collaborative Registry as part of an expanded Target-LD Protocol.  

Networking: Connections Fuel Us  

  • AASLD had an 82% retention rate with 7,132 Members.
  • New co-editors, Dr. Carmen Chak-Lui Wong and Dr. Elliot Tapper officially began their terms leading Hepatology Communications.  
  • Dr. Joseph Lim was selected as Editor for Clinical Liver Disease.  
  • In January 2023, AASLD’s Governing Board approved the formation of a SIG Advisory Task Force to evaluate SIG policies and procedures around SIG governance, nominations and elections, educational programming, and workflows.  
  • In May 2023, during the inaugural LLC Summit, representatives from the Inclusion & Diversity Committee, the Women’s Initiative Committee, and the LGBTQ Task Force participated in a panel discussion on Diversity, Equity, and Inclusion (DEI).
  • At TLM and DDW, AASLD organized DEI joint sessions hosted by the Inclusion & Diversity and Women’s Committees.

Funding Tomorrow’s Hepatology Heroes, Today  

  • AASLD Foundation granted $2 million to support 148 individuals in their hepatology career journey.  
  • 716 AASLD Members made a gift to AASLD Foundation in Fiscal Year 2023.  
  • 72% of members serving on a Committee or SIG Committee made a gift to the Foundation during the 2023 Leadership Giving Challenge.  
  • 40% of teams competing in the 2023 Leadership Giving Challenge had 100% participation with the Women’s Initiative Committee being named the challenge winner.